FDA Will Enforce NDI Notification Requirement Without Warning
This article was originally published in The Tan Sheet
Executive Summary
FDA likely will not issue warnings before taking judicial actions against firms that fail to comply with the new dietary ingredient notification regulation once the agency publishes a long-awaited guidance
You may also be interested in...
NDI Notification Enforcement Ramp-Up Likely To Target “Low-Hanging Fruit”
Legitimate supplement firms should not need phased-in enforcement of the new dietary ingredient notification regulations, says Anthony Young, general counsel to the American Herbal Products Association.
Low NDI Notice Compliance Sets Stage For Enforcement – FDA’s Fabricant
The volume of noncompliant supplement ingredients on the market likely will prompt an uptick in enforcement after FDA releases its NDI notification guidance, which will draw attention to the problem, dietary supplement program chief Daniel Fabricant says.
Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.